Skip to content

Author

V. Navghare

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

EVOLVING REGULATORY POLICIES FOR ORPHAN DRUGS POST-COVID-19: UK AND INDIAN PERSPECTIVES

Background: Globally, rare diseases affect around 300 million people, but most of these disorders lack approved treatments. Orphan drugs - pharmaceuticals for rare diseases - represent a special category of drugs, balancing the profit disincentive with the compelling need. The COVID-19 pandemic (2019-2023) has ushered...

Rohit Muneshwa, V. Navghare, Suryakant Jadhav et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.